Abstract. Overall diagnostic sensitivity is the probability that a diagnostic procedure will detect an agent if the tested animal is indeed infected. The overall or effective sensitivity is a function of both the probability that the assay will detect the agent if it is present in the sample tested and the probability that the agent will be present in the sample tested if the animal is infected with the agent. Thus, even with a highly sensitive assay, the probability of detecting an infected animal may be low or nil if the sampling procedure failed to capture the agent in samples tested by the assay. In this article, it is demonstrated how increased frequency of testing, such as testing multiple subsamples, can have a profound effect on increasing the overall sensitivity of a diagnostic procedure.
Laboratory-based diagnosis of many infectious diseases is based on the ability of the diagnostic detection system to identify the agent or evidence of the presence of the agent in the sample or subsample presented for testing. Typically, for a given animal, however, the probability that infection will be diagnosed is viewed as a function of the sensitivity (Se) and specificity (Sp) of the detection assay. Although this generality may be true some of the time, the probability of achieving a correct diagnosis for the animal is not necessarily equivalent to the Se and Sp of the diagnostic assay; rather, it is associated with parameters of diagnostic sampling that determine whether or not the sample contains the agent being tested. Even with a highly sensitive assay, the overall sensitivity relating to detection of a truly infected animal may be low or nil if the diagnostic sampling methods fail to capture the agent targeted by the assay.
Herein are illustrated the effects of the specific agent and sampling parameters on the proportion of test-positive outcomes and, ultimately, on the overall sensitivity of the diagnostic procedure for agent detection. These parameters include agent concentration, amount or volume of sample material, number of samples or subsamples taken, and the actual sensitivity, Se, of the diagnostic assay as it is applied to a single sample that is known to contain the agent in question.
The sensitivity of the diagnostic assay based on a single sample can be zero for some infected animals. For example, it is possible that an agent will not be detectable if the animal is in a latent or convalescent stage of infection, in which the agent is not present in the tissue or material being sampled. Such a possibility is referred to in this study as ''infected but agent is not present'' (AGNP). The presence of a detectable agent in a sample is termed agent present (AGP). Here, the proportion of animals that are AGNP is designated as q ϭ probability of AGNP or Pr(AGNP). As described hereafter, the probability of detecting the agent in AGP animals depends on the concentration of the agent in the tissue tested and on the volume (amount) of tissue tested, as well as the sensitivity of the assay used to detect the agent.
The diagnostic objective and general approach are as follows. A sample or perhaps multiple samples are collected from an animal for the purpose of determining infection status for a specific agent, where k ϭ the number of samples or subsamples collected from the animal. Each sample is tested separately and thus independently for the agent using a single diagnostic assay for agent detection, with outcomes being either test negative, T Ϫ , or test positive, T ϩ . The Se of the assay is the probability of T ϩ , given the agent (AG) is present in the sample. In this study, the distinction is made between AGNP and AGP cases. The standard definition of assay sensitivity in this context is that the Se of the test is the probability of T ϩ , given the agent is present in the sample or Pr(T ϩ ͦAGP), and the Sp of the test is the probability of T Ϫ , given the agent is not present in the sample or Pr(T Ϫ ͦnoAG). The sensitivity for an AGNP sample is
It is assumed that the volume of the material (V) in each sample may vary around the mean value or the volume may be fixed, as is the case for most assays. Thus, V may be either a random or a fixed quantity depending on the capability of the sampling technique and the standard operating procedure. Moreover, each infected animal has its own specific concentration (C) of the agent measured in units per volume of the tissue, secretions, or excretions being sampled. The value of C will vary from animal to animal depending on factors associated with the particular agent in question. For tissues or materials from some animals, C may be so small that it could be virtually impossible to obtain a sample that would contain the agent.
It also is assumed that the number of detectable units (NDU) of the agent in a sample of volume V follows a Poisson distribution in that units are not clumped; the probability of finding a single detectable unit in a small volume is proportional to R ϭ C ϫ V, and the NDUs in separate samples are independent (the number of units in one subsample is not predictive of the number of units in the other subsamples). Samples are obtained randomly so that the rate of detectable units per sample is R. These assumptions imply that the NDUs per sample can be regarded as a Poisson random variable 2 with rate, R, or For an animal that is AGP, therefore, the probability of at least 1 detectable unit in a single sample is p ϭ 1 Ϫ exp(ϪR).
Thus, there are 2 ways that a particular sample taken from an infected animal would result in NDU ϭ 0. First, it will happen with certainty if the animal is in the AGNP category. Alternatively, it will happen by random chance with probability 1 Ϫ P for each sample of volume V taken from an animal in the AGP category with concentration C.
For AGP animals and given values of R and the assay Se, it is possible, using probability theory, to calculate the proportion of animals that would be detected with the agent. The probability of detection if k samples are obtained from the animal is
for AGP animals, and
Pr(Det ͦ AGNP) ϭ 0, for AGNP animals.
If only 1 sample is collected (k ϭ 1), the probability of detection for an AGP animal is p ϫ Se. Note that for k ϭ 1, the probability of detection is less than the assay Se. However, as k is increased, the value of {1 Ϫ (1 Ϫ p ϫ Se) k } tends to 1. So, with enough subsamples and even with Se Ͻ 1, it is possible eventually to detect the agent, provided the animal is AGP.
As an example, consider a diagnostic procedure for Salmonella infection in cattle whereby a sample of feces is collected from an animal and each of k swabs (subsamples) of the sample is plated on separate culture plates. Assume that 80% of infected cattle will have sufficient bacteria in the feces to be detectable by the culture plate method, namely, (1 Ϫ q) ϭ 0.80 (80% are AGP), and the Se of the culture method is 0.95. For purposes of illustration, it is assumed that the concentration is 30 bacteria/g in the cattle feces and a swab deposits, on average, 0.1 g of fecal material on the culture plate. Thus, R ϭ 3; consequently, p ϭ 1 Ϫ exp(Ϫ3) ϭ 0.95 (95% of the swabs will deposit at least 1 detectable bacterium on the culture plate). For a single swab, the probability of detection for AGP animals is 0.95 ϫ Se or 0.95 ϫ 0.95 ϭ 0.902. As illustrated in Table 1 , the probability that the diagnostic process will detect the agent increases as the number of samples, k, increases. Thus, the effect of low assay Se on overall probability of detection can be rectified by increasing the number of samples tested. If R ϭ 1, the probability of detection among AGP animals decreases to 0.63 ϫ 0.95 ϭ 0.60 for k ϭ 1. For k ϭ 2, 4, and 8, the probability of detection would be 0.84, 0.974, and 0.9993, respectively. Thus, high R values would promote higher probabilities of detection. A previous report has described how sensitivity can be affected by sample weight and by homogenization of sample material, if the assumption of no clumping is inappropriate. 1 A practical issue in estimating the probability of detection relates to the lack of information about values for C and V, which are needed to calculate R. Estimates for these values should be available from assay validation experiments that quantify the concentration of detectable units and measure the volume of samples for representative infected animals to be targeted for the assay. Average values for C and V then could be identified, which would provide an average value for R. The probability calculated using this value of R would represent the probability for the average AGP animal; probabilities for individual infected animals would be larger or smaller than the calculated value because the value of R would be expected to vary for each animal. If the standard operation procedure for an assay allows only for a single value of V, as is the usual case, then R would vary only with C. Modification of standard operating procedures to accom- * Se* refers to the sensitivity of the overall diagnostic procedure. R is the rate of detectable agent in a sample. † Se of the assay. ‡ AGP refers to animals for which the agent is present in samples tested.
Figure 1.
Schematic of sampling and testing illustrating how overall sensitivity (Se*) of a diagnostic procedure is affected sequentially by parameters that include whether the agent is present (AGP) or not (AGNP) in tissues tested, the R value, which is a function of agent concentration and volume of sample tested, the assay sensitivity (Se), and the number of subsamples tested from each animal (k). modate a larger V that would result in a larger value for R, may be indicated if multiple-sample testing is envisioned.
The probability of detection calculated above for the Salmonella example was obtained under the presumption that the animal was in the AGP category. This probability represents the overall sensitivity among AGP animals. Thus, if only half the infected animals were AGP, the overall sensitivity of the diagnostic procedure in detecting an infected animal based on a single sample would only be half the value calculated for the probability of detecting the agent. The sensitivity of the overall diagnostic procedure, Se*, is thus obtained as
Observe that because the probability of detection tends to 1 as k increases, the largest value that Se* can have is (1 Ϫ q). The specificity of the overall diagnostic procedure is Sp* ϭ Pr(not DetͦnotAG, Sp) ϭ Sp k .
A sampling and testing schematic is given in Fig. 1 , to illustrate for this example how overall sensitivity is affected by the AGP/AGNP status, the R value, the assay Se, and the number of subsamples tested.
Of particular interest to the diagnostician is the probability that an animal that tested positive is actually infected with the agent (AG) and the probability that an animal that tested negative is actually not infected with the agent (notAG). These respective probabilities are referred to as the positive predictive value (PPV) and the negative predictive value (NPV) and are indicated as Pr(AGͦDet) and Pr(notAGͦnot Det), respectively. Calculation of predictive values is made using the Bayes formula and requires an estimate of the prevalence of the agent (Prev) in the herd in which the tested animal is located, as well as the Se* and Sp* of the overall diagnostic procedure.
Assuming Prev is the proportion of animals with the agent in the herd that was sampled, calculation of PPV is as follows. Let a ϭ (Prev)(Se*), the proportion of overall true- To calculate the PPV, using the Salmonella example, the prevalence of infection in the herd is assumed to be 0.10, R to be 3, and assay Se and Sp to be 0.95 and 0.98, respectively. Recall that 80% of the animals were AGP or (1 Ϫ q) Figure 2 illustrates how the PPV* and NPV* would be affected by the number of subsamples tested and by prevalence. Table 1 presents estimated values of overall diagnostic procedure Se* for various values of assay Se and numbers of subsamples, k. As Se* increases with increasing k, the overall Sp* declines or equivalently the false-positive probability rate (1 Ϫ Sp k ) increases. Consequently, as can be seen in Fig. 2 , the PPV* will decline as the number of subsamples increases. Thus, it is desirable to increase k only enough to bring the Se* near 1.0 for AGP animals, and further increases in k are not warranted.
As expected for any diagnostic procedure, sensitivity and specificity generally will vary inversely; thus, any increase in Se* achieved as a result of multiple-sample testing will be born at the expense of diminished Sp*. Moreover, supplemental labor and materials necessary to accommodate additional sample processing and testing would increase laboratory costs associated with multiple-sample testing. The benefit derived from multiple-sample testing (i.e., an improved ability to detect an infected animal), therefore, should be weighed against the increased costs associated with undertaking multiple-sampling procedures, as well as the implications of an increased likelihood of false-positive results.
In summary, simple probability calculations given in this study allow for the estimation of the overall sensitivity of a diagnostic procedure, taking into account agent concentration, sample volume, and frequency of sampling from the same animal or sample, as well as assay Se and Sp of the agent detection assay. The calculations demonstrate that large sample volume and multiple sampling have a clear effect on increasing the sensitivity of the overall diagnostic procedure and that assay Se alone should not be considered to represent the probability that the diagnostic process will detect infection in a truly infected animal. Increasing the number of samples tested from an animal can substantially increase the sensitivity of the overall diagnostic process, with the caveat that specificity will decline.
